In MCAO rats, resveratrol pretreatment could enhance the SIRT1 activity, thus decreasing the levels of p53 and caspase3, and improving ischemic stroke by inhibiting cell apoptosis [187]. The gene discussed is SIRT1; the disease is ischemic stroke.